Maxine Liu Selected as a Utah Business 2024 Forty Under 40 Honoree

Posted in Feature Articles
Maxine Liu photo

Maxine Liu, Health Catalyst’s Senior Vice President of M&A Integration and General Manager of Interoperability, has been selected as a Utah Business 2024 Forty Under 40 Honoree. The 40 Under 40 awards program celebrates Utah’s leading professionals by showcasing how they advance the future of business across the state.

Maxine’s role at Health Catalyst includes collaborating with partners and vendors to integrate their technologies and offerings to collectively meet the needs of clients.

Her impressive skills and expertise have positioned her as an exceptional strategy executive, prominently guiding M&A strategy and integration, operations, partnerships, and product/technology strategy and development. Leveraging her extensive global experiences in the United States, Asia, and Europe, she adeptly applies strategic approaches to ensure a continual focus on healthcare improvement.

“Maxine’s dedication to thoughtful innovation for the healthcare industry as well as elevating Health Catalyst by facilitating the growth and learning of acquired entities.”

“I have immense gratitude for Maxine’s many contributions to Health Catalyst. Her daily efforts to advance our business and product strategy elevate our position in the industry. But more importantly, she is a thoughtful, kind, and hard-working servant leader and team member. We are proud to celebrate her and this wonderful achievement,” said TJ Elbert, Chief Data Officer & General Manager, Data Platform at Health Catalyst.

Maxine’s achievement will be featured in the February 2024 edition of Utah Business, and she will receive recognition at an awards luncheon at The Grand America Hotel on February 22, 2024. Join us in celebrating Maxine’s outstanding achievement!

Health Catalyst’s Able Health Registry Receives CMS’s QPP Qualified Registry Approval for 2024

This website stores data such as cookies to enable essential site functionality, as well as marketing, personalization, and analytics. By remaining on this website you indicate your consent. For more information please visit our Privacy Policy.